Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Spaeth

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
American Journal of Hematology|May 18, 2000
Elevation of soluble Fas and soluble Fas ligand in reactive macrophage activation syndromesU Emmenegger, R Zehnder, U Frey, et al.
Clinical and Experimental Immunology|August 1, 1987
Tetanus toxoid-anti-tetanus toxoid complexes: a potential model to study the complement transport system for immune complex in humansJ P Paccaud, G Steiger, A G Sjöholm, et al.
The Journal of Rheumatology|July 1, 1991
Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapyA Corvetta, G Pomponio, R Bencivenga, et al.
The International Journal of Artificial Organs|August 31, 1999
Effects of unprocessed and processed cardiopulmonary bypass blood retransfused into patients after cardiac surgeryB H Walpoth, N Eggensperger, S P Hauser, et al.
Diagnostic Immunology|January 1, 1983
Complement activation and impaired capacity to solubilize immune complexes or to prevent their formation in essential mixed cryoglobulinemiaA Corvetta, P J Spaeth, P A Ghirelli, et al.
American Journal of Hematology|September 18, 2001
Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromesU Emmenegger, U Frey, A Reimers, et al.
Clinical and Experimental Rheumatology|April 1, 1984
An immunochemical study of the synovial fluid can contribute to the distinction between rheumatoid and non rheumatoid arthritisA Corvetta, P A Ghirelli, P J Spaeth, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1989
[Serum immunoglobulin concentrations in patients following bone marrow transplantation and preventive administration of high-dose nonspecific or normal-dose CMV-specific immunoglobulin]C Berger, A Gratwohl, J E Doran, et al.
The International Journal of Artificial Organs|April 1, 1997
Qualitative assessment of blood washing with the continuous autologous transfusion system (CATS)B H Walpoth, N Eggensperger, B N Walpoth-Aslan, et al.
Swiss Medical Weekly|June 28, 2002
Reactive macrophage activation syndrome: a simple screening strategy and its potential in early treatment initiationU Emmenegger, A Reimers, U Frey, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
American Journal of Hematology|May 18, 2000
Elevation of soluble Fas and soluble Fas ligand in reactive macrophage activation syndromesU Emmenegger, R Zehnder, U Frey, et al.
Clinical and Experimental Immunology|August 1, 1987
Tetanus toxoid-anti-tetanus toxoid complexes: a potential model to study the complement transport system for immune complex in humansJ P Paccaud, G Steiger, A G Sjöholm, et al.
The Journal of Rheumatology|July 1, 1991
Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapyA Corvetta, G Pomponio, R Bencivenga, et al.
The International Journal of Artificial Organs|August 31, 1999
Effects of unprocessed and processed cardiopulmonary bypass blood retransfused into patients after cardiac surgeryB H Walpoth, N Eggensperger, S P Hauser, et al.
Diagnostic Immunology|January 1, 1983
Complement activation and impaired capacity to solubilize immune complexes or to prevent their formation in essential mixed cryoglobulinemiaA Corvetta, P J Spaeth, P A Ghirelli, et al.
American Journal of Hematology|September 18, 2001
Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromesU Emmenegger, U Frey, A Reimers, et al.
Clinical and Experimental Rheumatology|April 1, 1984
An immunochemical study of the synovial fluid can contribute to the distinction between rheumatoid and non rheumatoid arthritisA Corvetta, P A Ghirelli, P J Spaeth, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1989
[Serum immunoglobulin concentrations in patients following bone marrow transplantation and preventive administration of high-dose nonspecific or normal-dose CMV-specific immunoglobulin]C Berger, A Gratwohl, J E Doran, et al.
The International Journal of Artificial Organs|April 1, 1997
Qualitative assessment of blood washing with the continuous autologous transfusion system (CATS)B H Walpoth, N Eggensperger, B N Walpoth-Aslan, et al.
Swiss Medical Weekly|June 28, 2002
Reactive macrophage activation syndrome: a simple screening strategy and its potential in early treatment initiationU Emmenegger, A Reimers, U Frey, et al.
Pageof 2